Intellia Therapeutics, Inc.
US ˙ NasdaqGM ˙ US45826J1051

SecurityNTLA / Intellia Therapeutics, Inc.
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in NTLA / Intellia Therapeutics, Inc.

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of Intellia Therapeutics, Inc. (US:NTLA) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 20,000 shares of Intellia Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 0 -20,000 -100.00 0 -100.00
2025-11-13 2025-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 20,000 0 0.00 345 83.51 0.0004
2025-08-14 2025-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 20,000 0 0.00 188 32.39 0.0002
2025-08-14 2025-03-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 20,000 0 0.00 142 -39.06 0.0002
2025-05-15 2025-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 20,000 0 142 0.0001
2025-02-14 2024-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 20,000 0 0.00 233 -43.31 0.0003
2024-11-14 2024-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 20,000 0 0.00 411 -8.26 0.0004
2024-08-09 2024-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 20,000 0 0.00 448 -18.55 0.0005
2024-05-14 2024-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 20,000 0 0.00 550 -9.84 0.0006
2024-02-14 2023-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 20,000 0 0.00 610 -3.48 0.0007
2023-11-14 2023-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 20,000 0 0.00 632 -22.55 0.0008
2023-10-27 2023-06-30 13F/A-2 INTELLIA THERAPEUTICS COM 45826J105 20,000 0 0.00 816 9.53 0.0009
2023-10-12 2023-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 20,000 0 816 0.0008
2023-08-14 2023-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 20,000 0 816 0.0008
2023-06-01 2023-03-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 20,000 0 0.00 745 6.73 0.0009
2023-05-15 2023-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 20,000 0 745 0.0007
2023-02-21 2022-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 20,000 -479 -2.34 698 -41.34 0.0008
2022-11-14 2022-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 20,479 -793 -3.73 1,190 8.08 0.0015
2022-08-17 2022-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 21,272 0 0.00 1,101 -28.74 0.0012
2022-08-15 2022-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 21,272 0 1,101 0.0004
2022-05-16 2022-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 21,272 0 0.00 1,545 -38.57 0.0012
2022-02-11 2021-12-31 13F INTELLIA Therapeutics COM 45826J105 21,272 -287 -1.33 2,515 -13.04 0.0021
2021-11-12 2021-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 21,559 730 3.50 2,892 -14.23 0.0025
2021-08-13 2021-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 20,829 -528 -2.47 3,372 96.73 0.0028
2021-05-14 2021-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 21,357 -416 -1.91 1,714 44.76 0.0024
2021-02-16 2020-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 21,773 0 0.00 1,184 173.44 0.0017
2020-11-13 2020-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 21,773 0 0.00 433 -5.25 0.0007
2020-08-11 2020-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 21,773 21,773 457 0.0008
2019-05-15 2019-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 0 -300 -100.00 0 -100.00
2019-02-15 2018-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 300 200 200.00 4 33.33 0.0000
2018-11-15 2018-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 100 -3,600 -97.30 3 -97.03 0.0000
2019-03-21 2018-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 3,700 3,700 101 0.0002
2018-08-14 2018-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 3,700 101 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.